Metraipolis › archive › dc_fc99b6c39b49

Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case… — Europe PMC PMID:41607553

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41607553
DOI
10.1093/ehjcr/ytaf608
License (as archived)
solo-consultazione
Archived
2026-11-08T05:03:56.713Z
SHA-256 of the archived text
31b1609f8b6724b2a9aa5d55acebc472b4b258a343a7bd2aa4c5c6d540032785
Stable URL of this page
https://metraipolis.com/documento/dc_fc99b6c39b49

How to cite

Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case… — Europe PMC PMID:41607553 — Europe PMC (en), https://europepmc.org/article/MED/41607553 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc99b6c39b49 (Metraipolis archive dc_fc99b6c39b49, sha256 31b1609f8b6724b2a9aa5d55acebc472b4b258a343a7bd2aa4c5c6d540032785)
BibTeX
@misc{dcfc99b6c39b49,
  title = {Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case… — Europe PMC PMID:41607553},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41607553},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc99b6c39b49; sha256 31b1609f8b6724b2a9aa5d55acebc472b4b258a343a7bd2aa4c5c6d540032785},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41607553. Agents can read the archived copy with the MCP tool read_document.